- Home
- CISO vs LSTA Comparison
CISO vs LSTA Comparison
Compare CISO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- LSTA
- Stock Information
- Founded
- CISO 2015
- LSTA 1980
- Country
- CISO United States
- LSTA United States
- Employees
- CISO N/A
- LSTA N/A
- Industry
- CISO Computer Software: Prepackaged Software
- LSTA Misc Health and Biotechnology Services
- Sector
- CISO Technology
- LSTA Health Care
- Exchange
- CISO Nasdaq
- LSTA Nasdaq
- Market Cap
- CISO 12.4M
- LSTA 20.0M
- IPO Year
- CISO N/A
- LSTA N/A
- Fundamental
- Price
- CISO $1.07
- LSTA $2.21
- Analyst Decision
- CISO
- LSTA Strong Buy
- Analyst Count
- CISO 0
- LSTA 1
- Target Price
- CISO N/A
- LSTA $15.00
- AVG Volume (30 Days)
- CISO 393.3K
- LSTA 17.1K
- Earning Date
- CISO 04-15-2025
- LSTA 02-27-2025
- Dividend Yield
- CISO N/A
- LSTA N/A
- EPS Growth
- CISO N/A
- LSTA N/A
- EPS
- CISO N/A
- LSTA N/A
- Revenue
- CISO $54,633,909.00
- LSTA $1,000,000.00
- Revenue This Year
- CISO $78.76
- LSTA N/A
- Revenue Next Year
- CISO N/A
- LSTA N/A
- P/E Ratio
- CISO N/A
- LSTA N/A
- Revenue Growth
- CISO 34.87
- LSTA N/A
- 52 Week Low
- CISO $0.26
- LSTA $2.05
- 52 Week High
- CISO $3.84
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CISO 48.76
- LSTA 38.28
- Support Level
- CISO $0.96
- LSTA $2.05
- Resistance Level
- CISO $1.10
- LSTA $2.46
- Average True Range (ATR)
- CISO 0.14
- LSTA 0.20
- MACD
- CISO 0.01
- LSTA 0.01
- Stochastic Oscillator
- CISO 48.42
- LSTA 32.81
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.